Peter Nawroth
Inventor
Stats
- 2 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 4 US Applications Filed
- 1 Total Citation Count
- Aug 16, 2023 Most Recent Filing
- May 8, 1998 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| Merckle GmbH | 1
| 1998
|
| RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG | 2
| 2010
|
Inventor Addresses
| Address | Duration |
|---|---|
| Leimen, DE | May 10, 12 - Jan 25, 24 |
| Tübingen, DE | Aug 16, 05 - Aug 16, 05 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C07K: | PEPTIDES | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0025,960 | 2024 | RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES | 0 |
| 2020/0140,518 | 2020 | RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES | 0 |
| 8609810 | 2013 | Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia | 0 |
| 2012/0115,789 | 2012 | Methylglyoxal-Scavenging Compounds and Their Use for the Prevention and Treatment of Pain and/or Hyperalgesia | 0 |
| 6930094 | 2005 | Tissue factor for influencing blood vessel formation | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.